Hiroshi Ikeda
2 votes
The monoclonal antibody nBT062 conjugated to maytansinoids has potent and selective cytotoxicity against CD138 positive multiple myeloma cells in vitro and in vivo
CD138 (Syndecan1) is highly expressed on multiple myeloma (MM) cells. In this study, we examined the anti-MM effect of murine/human chimeric CD138-specific monoclonal antibody (mAb) nBT062 conjugat…
Received 07 October 2008 22:33 UTC; Posted 08 October 2008
Posted to: Cancer, Molecular Cell Biology
